PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Policresulen→

Policresulen PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
101418-00-2
Molecular formula
Not available
Molecular weight
Not available
Drug class
Topical antiseptic and astringentacidic polycondensation polymer
Mechanism of action
A highly acidic polymeric compound that coagulates proteins in damaged or infected tissue and has local antimicrobial, haemostatic and astringent effects. It promotes demarcation and removal of devitalised tissue while supporting epithelial regeneration in selected formulations.
Indications / reported uses
  • Local treatment of selected vaginal and cervical infections and lesions, including bacterial vaginosis and cervical ectopy, where authorised.
  • Topical use in selected oral, dental and wound preparations is product-specific; the exact formulation and route determine the approved use.

Sources: https://www.ncbi.nlm.nih.gov/books/NBK547948/ · https://pubchem.ncbi.nlm.nih.gov/#query=policresulen · https://www.medicines.org.uk/emc/product/ · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Policresulen PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Policresulen Permitted Daily Exposure (PDE) report (the Policresulen PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Policresulen Occupational Exposure Limit (OEL) report (the Policresulen OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.